Sensus Healthcare, Inc. (SRTS) Lags Q4 Earnings Estimates

Core Insights - Sensus Healthcare, Inc. reported quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of$ 0.10 per share, and down from $0.26 per share a year ago, representing an earnings surprise of -10% [1] - The company posted revenues of$ 13.07 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 32.59%, compared to year-ago revenues of $12.57 million [2] - Sensus Healthcare shares have increased approximately 22% since the beginning of the year, outperforming the S&P 500's gain of 2.7% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is$ 0.15 on revenues of $11.46 million, and for the current fiscal year, it is$ 0.71 on revenues of $49.34 million [7] - The estimate revisions trend for Sensus Healthcare is mixed, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Industry Context - The Medical - Instruments industry, to which Sensus Healthcare belongs, is currently in the top 34% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Another company in the same industry, Nevro, is expected to report a quarterly loss of$ 0.79 per share, reflecting a year-over-year change of -426.7%, with revenues projected at $105.65 million, down 9.1% from the previous year [9]